dan-comaniciu-shutterstock-com

Dan Comaniciu / Shutterstock.com

16 September 2016Big PharmaSarah Porch

Preview: Life Sciences IP Summit 2016

C5’s Life Sciences IP Summit returns for its third year, offering a comprehensive programme that is bursting with variety, topical relevance and focused discussion on the issues that really matter.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

GSK triumphs in EPO appeal, revoking Pfizer patent

‘We took Ravgen head-on’: How we won zero-damages and others didn't

Herbert Smith Freehills and Kramer Levin in $2bn merger talks

Teva fights for re-listing of inhaler patents at US appeals court

White & Case hires experienced litigator from A&O Shearman